On Monday, Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) opened lower -5.33% from the last session, before settling in for the closing price of $21.19. Price fluctuations for TNXP have ranged from $6.76 to $130.00 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 73.03% over the last five years. Company’s average yearly earnings per share was noted 91.80% at the time writing. With a float of $8.76 million, this company’s outstanding shares have now reached $8.77 million.
Tonix Pharmaceuticals Holding Corp (TNXP) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.08%, while institutional ownership is 15.98%. The most recent insider transaction that took place on Aug 21 ’25, was worth 15,061. In this transaction Director of this company bought 418 shares at a rate of $36.03, taking the stock ownership to the 418 shares. Before that another transaction happened on Aug 20 ’25, when Company’s Director bought 250 for $36.00, making the entire transaction worth $9,000. This insider now owns 250 shares in total.
Tonix Pharmaceuticals Holding Corp (TNXP) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -25.56 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -736) by 710.44. Wall Street market experts anticipate that the next fiscal year will bring earnings of -3.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 91.80% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 88.07% during the next five years compared to 73.03% growth over the previous five years of trading.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
Check out the current performance indicators for Tonix Pharmaceuticals Holding Corp (TNXP). In the past quarter, the stock posted a quick ratio of 7.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1006.28, a number that is poised to hit -3.58 in the next quarter and is forecasted to reach -8.61 in one year’s time.
